0000899243-18-011409.txt : 20180503 0000899243-18-011409.hdr.sgml : 20180503 20180503192322 ACCESSION NUMBER: 0000899243-18-011409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louks Ronald Allen CENTRAL INDEX KEY: 0001706849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37792 FILM NUMBER: 18805599 MAIL ADDRESS: STREET 1: C/O NANTHEALTH, INC. STREET 2: 9920 JEFFERSON BLVD. CITY: CULVER CITY STATE: CA ZIP: 90232 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NantHealth, Inc. CENTRAL INDEX KEY: 0001566469 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 273019889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 BUSINESS PHONE: (310) 853-7513 MAIL ADDRESS: STREET 1: 9920 JEFFERSON BLVD CITY: CULVER CITY STATE: CA ZIP: 90232 FORMER COMPANY: FORMER CONFORMED NAME: Nant Health, LLC DATE OF NAME CHANGE: 20130108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-01 0 0001566469 NantHealth, Inc. NH 0001706849 Louks Ronald Allen C/O NANTHEALTH, INC. 9920 JEFFERSON BLVD. CULVER CITY CA 90232 0 1 0 0 Chief Operating Officer Common Stock 2018-05-01 4 M 0 125196 A 204886 D Common Stock 2018-05-01 4 F 0 37495 3.39 D 167391 D Restricted Stock Units 2018-05-01 4 M 0 125196 0.00 D Common Stock 125196 250391 D Each restricted stock unit ("RSU") is the economic equivalent of one share of NantHealth, Inc. common stock. Subject to the Reporting Person's continuing to be a service provider (as defined in the 2016 Equity Incentive Plan) through each applicable vesting date, 25% of the RSUs shall vest on November 6, 2017, with the remaining 75% of the RSUs to vest annually in equal installments, beginning on May 1, 2018. Upon vesting, the issuer will withhold shares sufficient to satisfy tax withholding obligations; the issuer will then be responsible for remitting a cash payment for the related withholding taxes; and the issuer will issue to the Reporting Person a net lower number of shares. Exhibit 24 - Power of Attorney /s/ Brandon Villery, as Attorney-in-Fact 2018-05-03 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                                                      Exhibit 24

                               POWER OF ATTORNEY

     The undersigned, as a Section 16 reporting person of NantHealth, Inc. (the
"Company"), hereby constitutes and appoints Patrick Soon-Shiong, Brandon
Villery, Paul Holt, Charles Kim, Thomas Hornish, Martin Waters, and Kathryn
Fortin the undersigned's true and lawful attorneys-in-fact to:

     1.   complete and execute Forms 3, 4 and 5 and other forms and all
          amendments thereto as such attorneys-in-fact shall in their discretion
          determine to be required or advisable pursuant to Section 16 of the
          Securities Exchange Act of 1934 (as amended) and the rules and
          regulations promulgated thereunder, or any successor laws and
          regulations, as a consequence of the undersigned's ownership,
          acquisition or disposition of securities of the Company; and

     2.   do all acts necessary in order to file such forms with the Securities
          and Exchange Commission, any securities exchange or national
          association, the Company and such other person or agency as the
          attorneys-in-fact shall deem appropriate.

     The undersigned, as a Section 16 reporting person of the Company, hereby
revokes any and all prior powers of attorney previously signed by the
undersigned.

     The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agent shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 2nd day of May, 2018.


                                  Signature: /s/ Ronald Allen Louks
                                             -----------------------------

                                  Print Name: Ronald Allen Louks
                                             -----------------------------